WHO ICTRP trial
A placebo-controlled study to investigate the impact of DiamydTM on the diabetic…
EUCTR2004-001998-25-SE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2004-001998-25-SE |
|---|---|
| Public title | A placebo-controlled study to investigate the impact of DiamydTM on the diabetic status of patients with LADA (Latent Autoimmune Diabetes in Adult). |
| Scientific title | A placebo-controlled study to investigate the impact of DiamydTM on the diabetic status of patients with LADA (Latent Autoimmune Diabetes in Adult). |
| Primary sponsor | Diamyd Therapeutics AB |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Sweden |
| Conditions | Patients for the proposed study are those with Latent Autoimmune Diabetes in Adults (LADA). The presence of GAD 65 antibodies in this group identifies a single category of diabetes patients with ongoing auto-immunity to GAD65. |
| Interventions | Product Name: Diamyd Product Code: rh GAD65 Pharmaceutical Form: Solution for injection Current Sponsor code: rhGAD65 Concentration unit: µg/ml microgram(s)/millilitre Concentration type: equal Concentration number: 13.3- Pharmaceutical… |
| Registration date | Jul 30, 2004 |
| Target size | 160 |
| Secondary IDs | D/P2/04/2 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: